Table 6 Patient demographics.
Haplotype 1 | P value | ||
|---|---|---|---|
Carriers | Non-carriers | ||
Age | 63 (13) | 64 (12) | 0.68 |
Gender: | |||
Male | 68 (60%) | 44 (53%) | 0.38 |
Female | 46 (40%) | 39 (47%) | |
Tumour diagnosis: | |||
Urological | 38 | 19 | 0.80 |
Lung | 20 | 17 | |
Breast | 25 | 19 | |
Gastrointestinal | 7 | 10 | |
Haematological | 10 | 6 | |
Others | 14 | 12 | |
Karnofsky performance status | 67 (14) | 66 (13) | 0.36 |
Creatinine serum (μmol/l) | 86 (28) | 87 (39) | 0.48 |
Albumin serum (g/l) | 33 (5) | 32 (5) | 0.12 |
Time since diagnosis (months) | 45 (52) | 31 (43) | 0.03a |
Time since morphine treatment started (months) | 3.4 (7.8) | 3.6 (5.9) | 0.47 |
Survival time after study (months) | 5.7 (6.2) | 4.8 (5.5) | 0.23 |